Resources

In our latest blog, Isabel Vincent, Market Development Manager at Firefinch Software, shares how the team is driving innovation with custom software, harnessing AI and exploring cutting-edge imaging technologies, helping to shape the future of biotech and MedTech.

Discovery Park today announced the arrival of two pioneering biotech companies to its innovation campus.

Asymchem, has announced a significant expansion of its flow chemistry capabilities at its Sandwich, UK facility.

PHARMExcel is celebrating recognition of TOP UK CRO wholeheartedly as an acknowledgement of its efforts to create a distinctive niche in the Contract Research Organisation (CRO) industry, one which balances the commercial and scientific objectives of the biotech/researcher with the practical clinical trial delivery challenges and positive patient outcomes.

In the third part of our series on Industrial Strategy, Lewis Miles and Maddie Cass provide a deep dive into the Digital and Technologies Sector Plan, analysing how these policies aim to foster growth in the UK's life sciences and engineering biology sectors. We also look forward to strengthening relations and gaining key insight from our US sister organisation with BIO's upcoming UK visit.

In the third instalment of our updates on new Government policy, Lewis Miles and Maddie Cass from BIA’s Policy and Public Affairs team take a deep dive into the Industrial Strategy and the Digital and Technologies Sector Plan, breaking down the implications for engineering biology and the wider life sciences sector.  

Myricx Bio (‘Myricx’), a UK-based biotech company focusing on the discovery and development of a completely novel class of payloads for antibody-drug conjugates (ADCs), is pleased to announce the appointment of Penny Fatato in the newly created position of Global Head of Clinical Operations, based in Philadelphia, Pennsylvania, USA.

In this blog, Emma Lawrence, Head of Data Tech Policy and Public Affairs at BIA, explains why BIA is publishing a health data access industry checklist to support data access.

In this blog, Charlotte shares how her experience as a mentee on the BIA’s Women in Biotech mentoring programme helped her build confidence, embrace her leadership style, and navigate the challenges of a growing career in biotech. 

In the second instalment of our blog series on new government policy, Lewis Miles and Linda Bedenik examine the UK's Trade and National Security strategies and what they mean for biotech.

In a shifting global landscape, we break down how the UK's new Trade and National Security strategies aim to future-proof our biotech sector.

This is the first-ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease.

First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst

Research conducted by Pioneer Group in collaboration with Beauhurst into the UK life sciences landscape reveals a growing trend of investment into more mature companies.

Discovery Park has partnered with global proptech leader Equiem to launch Discover More — a purpose-built app that redefines how people work, connect, and collaborate across the 220-acre site. Home to over 180 pioneering companies working across science and technology, the new app is designed to make every tenant’s day-to-day experience more efficient and better connected, supporting an active tenant community and innovation ecosystem.

Microbiotica announces that patient recruitment is complete in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.

Call for BIA Board candidates. We are delighted to invite nominations from individuals interested in joining the BIA Board.

Cotton Mouton Diagnostics (CMD), a cutting-edge UK-based diagnostics technology company, has received a half-a-million-pound investment from CPI Enterprises as part of the Innovate UK Catapult Investment Pilot.

Brainomix, a global leader in AI-powered imaging solutions in stroke and lung fibrosis, has announced the appointment of Anna Griffin as Chief Financial Officer, filling a key leadership role within the company following its recent £14 million Series C funding round.

The BioIndustry Association (BIA) is now inviting applications for its 2026 Charity Partnership.